Ivabradine Generics [uk] (Ivabradine Oxalate)

Ivabradine selectively blocks the funny (If) current in the sinoatrial node, slowing the pacemaker activity of the heart. This reduces the resting heart rate without affecting the strength of cardiac contraction.

The dose of ivabradine is individualized by the prescribing clinician based on the patient’s heart‑rate response, clinical condition, and tolerability. Exact dosing regimens are not provided here.

Safety data for ivabradine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

Enquire about Ivabradine Generics by submitting a request on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both ivabradine and beta‑blockers lower heart rate, but ivabradine does so by selectively inhibiting the If current without affecting myocardial contractility or blood pressure, whereas beta‑blockers act on adrenergic receptors and have broader cardiovascular effects.

Store ivabradine tablets at room temperature, below 25 °C, in the original packaging and protect them from moisture and direct sunlight to maintain product stability.

Ivabradine is taken orally, usually as a tablet, with or without food as directed by the prescriber. The exact timing and frequency depend on the individual treatment plan.

Serious risks include severe bradycardia, atrial fibrillation, symptomatic hypotension, and heart block. Patients should be monitored for these events, especially when combined with other heart‑rate‑lowering agents.

Ivabradine is contraindicated in patients with severe hepatic impairment, sick sinus syndrome, acute decompensated heart failure, or those taking strong CYP3A4 inhibitors. It should also be avoided in individuals with a resting heart rate below 50 bpm unless directed by a physician.